[HTML][HTML] Prolonged infusion of angiotensin II in apoE−/− mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm

DL Rateri, DA Howatt, JJ Moorleghen… - The American journal of …, 2011 - Elsevier
Angiotensin II (AngII) infusion initiates abdominal aortic aneurysm (AAA) development due
to medial disruption and results in luminal dilation and thrombus formation. The objective of …

Important role of nitric oxide in the effect of angiotensin-converting enzyme inhibitor imidapril on vascular injury

R Chen, M Iwai, L Wu, J Suzuki, LJ Min, T Shiuchi… - …, 2003 - Am Heart Assoc
To examine the possible role of the bradykinin-NO system in the action of ACE inhibitors, we
studied the effects of imidapril, an ACE inhibitor, on inflammatory vascular injury by using …

Local upregulation of interleukin-1 beta in aortic dissecting aneurysm: correlation with matrix metalloproteinase-2, 9 expression and biomechanical decrease

YF Jiang, LL Guo, LW Zhang, YX Chu… - Interactive …, 2019 - academic.oup.com
OBJECTIVES Our goal was to examine whether interleukin-1 beta (IL-1β) originates locally
and its possible relationship with matrix metalloproteinases (MMPs), apoptosis, elastin fibres …

[HTML][HTML] An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomised placebo …

G Kiru, C Bicknell, E Falaschetti, J Powell… - Health Technology …, 2016 - europepmc.org
Background Although data are inconsistent, angiotensin-converting enzyme inhibitors (ACE-
Is) have been associated with a reduced incidence of abdominal aortic aneurysm (AAA) …

[HTML][HTML] Chemical stabilization of the extracellular matrix attenuates growth of experimentally induced abdominal aorta aneurysms in a large animal model

D Simionescu, M Casco, J Turner, N Rierson, J Yue… - JVS-Vascular …, 2020 - Elsevier
Objective The goal of the present study was to test the safety and efficacy of chemical
stabilization of the arterial extracellular matrix as a novel nonoperative treatment of …

Resveratrol counteracts systemic and local inflammation involved in early abdominal aortic aneurysm development

D Palmieri, B Pane, C Barisione, G Spinella… - Journal of Surgical …, 2011 - Elsevier
BACKGROUND: Monocyte activation, macrophage infiltration, vascular oxidative stress and
matrix proteolysis are inflammatory key steps contributing to abdominal aortic aneurysm …

Improvement of aortic wall distensibility and reduction of oxidative stress by pioglitazone in pre-diabetic stage of Otsuka Long-Evans Tokushima fatty rats

T Tsuji, K Mizushige, T Noma, K Murakami… - … drugs and therapy, 2002 - Springer
We tested the hypothesis that pioglitazone (insulin sensitizer) reduces oxidative stress and
improves aortic wall distensibility in the pre-diabetic stage of Otsuka Long-Evans Tokushima …

[PDF][PDF] Animal models in the research of abdominal aortic aneurysms development

N Patelis, D Moris, D Schizas, C Damaskos… - Physiological …, 2017 - researchgate.net
Abdominal aortic aneurysm (AAA) is a prevalent and potentially life threatening disease.
Many animal models have been developed to simulate the natural history of the disease or …

[HTML][HTML] Tamoxifen up-regulates catalase production, inhibits vessel wall neutrophil infiltration, and attenuates development of experimental abdominal aortic …

V Grigoryants, KK Hannawa, CG Pearce, I Sinha… - Journal of vascular …, 2005 - Elsevier
BACKGROUND: Selective estrogen receptor modulators (SERMs), similar to estrogens,
possess vasoprotective effects by reducing release of reactive oxygen species. Little is …

[HTML][HTML] Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908)

G Moore, S Liao, JA Curci, BC Starcher… - Journal of vascular …, 1999 - Elsevier
Background: Abdominal aortic aneurysms (AAAs) are associated with chronic inflammation,
disruption of medial elastin, and increased local production of elastolytic matrix …